FindTrial
Sign In

The effect of low-dose remifentanil infusion on emergence agitation and POCD

The effect of low-dose remifentanil infusion on emergence agitation and POCD

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR1900024254
Enrollment
Unknown
Registered
2019-07-03
Start date
2019-07-15
Completion date
Unknown
Last updated
2019-07-15

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

EA and POCD

Interventions

experimental group :Remifentanil 0.1-0.2µg /( kg.min)
control group:Normal saline

Sponsors

First Affiliated Hospital, Zhejiang University School of Medicine
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 90 Years

Inclusion criteria

Inclusion criteria: 200 patients aged 18 to 90 years, weighing 40 to 100 kg, gender is not limited, ASA 1-3 grade, with emergence aditation.

Exclusion criteria

Exclusion criteria: Patients with previous severe heart, lung, liver or kidney disease, history of elevated intracranial pressure, long-term use of opioids, pregnancy, history of allergies to test medication, recent history of upper respiratory tract infection, history of chronic cough.

Design outcomes

Primary

MeasureTime frame
incidence of emergence agitation ;—

Secondary

MeasureTime frame
cognitive score;—

Countries

China

Contacts

Public ContactYongxing Yao

First Affiliated Hospital, Zhejiang University School of Medicine

yaoyongxing@zju.edu.cn+86 13656668373

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026